{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:07:17Z","timestamp":1781813237694,"version":"3.54.5"},"reference-count":88,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>A tumor cell carrying characteristic genomic alteration(s) exists within its host\u2019s microenvironment. The tumor microenvironment (TME) renders holistic support to the tumor via cross-talk between tumor cells and three components of TME, immune components, vascular components, and fibroblast components. The tempero-spatial interaction of tumor cells with its microenvironment is the deterministic factor for tumor growth, progression, resistance to therapy, and its outcome in clinics. TME (1) facilitates proliferation, and the ensuing metastasis-associated phenotypes, (2) perturbs immune surveillance and supports tumor cells in their effort to evade immune recognition, and (3) actively participates in developing drug-induced resistance in cancer cells. Cancer-Associated Fibroblast (CAF) is a unique component of TME. CAF is the host mesenchyme immediately surrounding the tumor cells in solid tumors. It facilitates tumor growth and progression and participates in developing drug resistance in tumor cells by playing a critical role in all the ways mentioned above. The clinical outcome of a disease is thus critically contributed to by the CAF component of TME. Although CAFs have been identified historically, the functional relevance of CAF-tumor cell cross-talk and their influence on angiogenic and immune-components of TME are yet to be characterized in solid tumors, especially in endometrial cancers. Currently, the standard of care for the treatment of endometrial cancers is primarily guided by therapies directed towards the disease\u2019s tumor compartment and immune compartments. Unfortunately, in the current state of therapies, a complete response (CR) to the therapy is still limited despite a more commonly achieved partial response (PR) and stable disease (SD) in patients. Acknowledging the limitations of the current sets of therapies based on only the tumor and immune compartments of the disease, we sought to put forward this review based on the importance of the cross-talk between CAF of the tumor microenvironment and tumor cells. The premise of the review is to recognize the critical role of CAF in disease progression. This manuscript presents a systemic review of the role of CAF in endometrial cancers. We critically interrogated the active involvement of CAF in the tumor compartment of endometrial cancers. Here we present the functional characteristics of CAF in the context of endometrial cancers. We review (1) the characteristics of CAF, (2) their evolution from being anti-tumor to pro-tumor, (3) their involvement in regulating growth and several metastasis-associated phenotypes of tumor cells, (4) their participation in perturbing immune defense and evading immune surveillance, and (5) their role in mediating drug resistance via tumor-CAF cross-talk with particular reference to endometrial cancers. We interrogate the functional characteristics of CAF in the light of its dialogue with tumor cells and other components of TME towards developing a CAF-based strategy for precision therapy to supplement tumor-based therapy. The purpose of the review is to present a new vision and initiate a thought process which recognizes the importance of CAF in a tumor, thereby resulting in a novel approach to the design and management of the disease in endometrial cancers.<\/jats:p>","DOI":"10.3390\/ijms22179121","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T22:12:22Z","timestamp":1629843142000},"page":"9121","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime"],"prefix":"10.3390","volume":"22","author":[{"given":"De","family":"Pradip","sequence":"first","affiliation":[{"name":"Translational Oncology Laboratory, Avera Cancer Institute, Sioux Falls, SD 57105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9405-5464","authenticated-orcid":false,"given":"Aske","family":"Jennifer","sequence":"additional","affiliation":[{"name":"Translational Oncology Laboratory, Avera Cancer Institute, Sioux Falls, SD 57105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dey","family":"Nandini","sequence":"additional","affiliation":[{"name":"Translational Oncology Laboratory, Avera Cancer Institute, Sioux Falls, SD 57105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","article-title":"Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing","volume":"9","author":"Bartoschek","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ganguly, D., Chandra, R., Karalis, J., Teke, M., Aguilera, T., Maddipati, R., Wachsmann, M.B., Ghersi, D., Siravegna, G., and Zeh, H.J. (2020). Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment. Cancers, 12.","DOI":"10.3390\/cancers12092652"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"Elyada","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","article-title":"Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment","volume":"99","author":"Ishii","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1084\/jem.20180818","article-title":"Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer","volume":"215","author":"Raz","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/0008-5472.CAN-12-0294","article-title":"Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment","volume":"72","author":"Zhang","year":"2012","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","article-title":"Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion","volume":"71","author":"Dirat","year":"2011","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ijc.32193","article-title":"In search of definitions: Cancer-associated fibroblasts and their markers","volume":"146","author":"Nurmik","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semcancer.2005.05.003","article-title":"Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression","volume":"15","author":"Beacham","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival","volume":"25","author":"Carstens","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and Biology of Cancer\u2014Associated Fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/cancers7040902","article-title":"Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth","volume":"7","author":"Shiga","year":"2015","journal-title":"Cancers"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/1541-7786.MCR-12-0307","article-title":"Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue","volume":"10","author":"Karagiannis","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","article-title":"Putting tumours in context","volume":"1","author":"Bissell","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103729","DOI":"10.1016\/j.cellimm.2017.12.003","article-title":"Cancer-associated fibroblasts in tumor microenvironment\u2014Accomplices in tumor malignancy","volume":"343","author":"Liao","year":"2019","journal-title":"Cell. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/omi.2020.0023","article-title":"Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance","volume":"24","author":"Dzobo","year":"2020","journal-title":"OMICS"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: Targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Walter, S.G., Scheidt, S., Ni\u00dfletr, R., Gaisendrees, C., Zarghooni, K., and Schildberg, F. (2021). In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets. Cancers, 13.","DOI":"10.3390\/cancers13061466"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","article-title":"Identification of fibroblast heterogeneity in the tumor microenvironment","volume":"5","author":"Sugimoto","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-016-2467-x","article-title":"Fibroblast activation in cancer: When seed fertilizes soil","volume":"365","author":"Kuzet","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-1542-z","article-title":"YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression","volume":"39","author":"Shen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_27","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1\/CXCL12 Secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14842","DOI":"10.1073\/pnas.0606857103","article-title":"Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation","volume":"103","author":"Sneddon","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","article-title":"Co-evolution of tumor cells and their microenvironment","volume":"25","author":"Polyak","year":"2009","journal-title":"Trends Genet."},{"key":"ref_31","first-page":"174","article-title":"Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer","volume":"39","author":"Cardone","year":"1997","journal-title":"Panminerva Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.oraloncology.2007.07.001","article-title":"Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: Induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation","volume":"44","author":"Kellermann","year":"2008","journal-title":"Oral Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"De Nola, R., Metnga, A., Castegna, A., Loizzi, V., Ranieri, G., Cicinelli, E., and Cormio, G. (2019). The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102401"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3892\/ol.2017.6497","article-title":"Cancer associated fibroblasts: An essential role in the tumor microenvironment","volume":"14","author":"Tao","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.gastro.2017.11.280","article-title":"Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer","volume":"154","author":"Vennin","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-10968-6","article-title":"CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan","volume":"10","author":"Vennin","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.1038\/s41598-017-07728-1","article-title":"Juxtacrine Activity of Estrogen Receptor alpha in Uterine Stromal Cells is Necessary for Estrogen-Induced Epithelial Cell Proliferation","volume":"7","author":"Winuthayanon","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01116850","article-title":"Inhibitory action of estradiol on growth promoting activity in extract from uterine cancers","volume":"10","author":"Imai","year":"1990","journal-title":"Biosci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/PGP.0000000000000233","article-title":"Stromal Clues in Endometrial Carcinoma: Loss of Expression of beta-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor","volume":"35","author":"Senol","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/09513599609097900","article-title":"Estrogen induces expression of c-fos and c-jun via activation of protein kinase C in an endometrial cancer cell line and fibroblasts derived from human uterine endometrium","volume":"10","author":"Fujimoto","year":"1996","journal-title":"Gynecol. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0960-0760(95)00145-P","article-title":"Estrogen induces c-Ha-ras expression via activation of tyrosine kinase in uterine endometrial fibroblasts and cancer cells","volume":"55","author":"Fujimoto","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/000456329503200509","article-title":"Oestrogen Induces C-Ha-Ras Expression in the Fibroblasts Derived from Human Uterine Endometrium","volume":"32","author":"Fujimoto","year":"1995","journal-title":"Ann. Clin. Biochem. Int. J. Lab. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12672-015-0223-4","article-title":"Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth","volume":"6","author":"Pineda","year":"2015","journal-title":"Horm. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Subramaniam, K.S., Tham, S.T., Mohamed, Z., Woo, Y.L., Adenan, N.A.M., and Chung, I. (2013). Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068923"},{"key":"ref_47","first-page":"200","article-title":"Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6\/STAT-3\/c-Myc pathway","volume":"6","author":"Subramaniam","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1006\/excr.1999.4430","article-title":"The Role of Interleukin-1 in Interactive Senescence and Age-Related Human Endometrial Cancer","volume":"248","author":"Rinehart","year":"1999","journal-title":"Exp. Cell Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/excr.1998.4341","article-title":"Age-related expression of PEDF\/EPC-1 in human endometrial stromal fibroblasts: Implications for interactive senescence","volume":"247","author":"Palmieri","year":"1999","journal-title":"Exp. Cell Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1541-7786.MCR-15-0307","article-title":"Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma","volume":"14","author":"Pankova","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-07875-9","article-title":"Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells","volume":"21","author":"Yoshida","year":"2021","journal-title":"BMC Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/07357907.2019.1575969","article-title":"Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene","volume":"37","author":"Wang","year":"2019","journal-title":"Cancer Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/labinvest.2009.52","article-title":"S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling","volume":"89","author":"Xie","year":"2009","journal-title":"Lab. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.1999.17.2.607","article-title":"Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma","volume":"17","author":"Maehara","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-6-56","article-title":"TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)","volume":"6","author":"Kasai","year":"2005","journal-title":"Respir. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-beta and epithelial-to-mesenchymal transitions","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"F563","DOI":"10.1152\/ajprenal.1997.273.4.F563","article-title":"Early role of Fsp1 in epithelial-mesenchymal transformation","volume":"273","author":"Okada","year":"1997","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1164\/rccm.200311-1535OC","article-title":"Characterization of Fibroblast-specific Protein 1 in Pulmonary Fibrosis","volume":"171","author":"Lawson","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","article-title":"Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts","volume":"67","author":"Zeisberg","year":"2007","journal-title":"Cancer Res."},{"key":"ref_60","first-page":"5694","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition through secreted cytokines in endometrial cancer cells","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2010.04.001","article-title":"Roles of small RNAs in tumor formation","volume":"16","author":"Croce","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.4161\/cc.9.21.13674","article-title":"The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts","volume":"9","author":"Aprelikova","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.4161\/cc.9.22.13822","article-title":"MicroRNAs are invading the tumor microenvironment: Fibroblast microRNAs regulate tumor cell motility and invasiveness","volume":"9","author":"Shurin","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neo.2021.05.004","article-title":"Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a\/b-5p-mediated STAT3\/YKL-40 signaling pathway","volume":"23","author":"Fan","year":"2021","journal-title":"Neoplasia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"112113","DOI":"10.1016\/j.yexcr.2020.112113","article-title":"Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1\u03b1\/VEGFA axis","volume":"394","author":"Zhang","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.onc.1205924","article-title":"Abnormalities of the APC\/beta-catenin pathway in endometrial cancer","volume":"21","author":"Hardisson","year":"2002","journal-title":"Oncogene"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1038\/onc.2012.351","article-title":"Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility","volume":"32","author":"Aprelikova","year":"2012","journal-title":"Oncogene"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1101\/gad.1820109","article-title":"MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer","volume":"23","author":"Olson","year":"2009","journal-title":"Genes Dev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hep.22160","article-title":"Identification of metastasis-related microRNAs in hepatocellular carcinoma","volume":"47","author":"Budhu","year":"2008","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1158\/0008-5472.CAN-08-1319","article-title":"Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts","volume":"68","author":"Jiang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/0008-5472.CAN-05-2508","article-title":"Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2\/neu Status in Primary Breast Cancer","volume":"66","author":"Fiegl","year":"2006","journal-title":"Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/jcp.27111","article-title":"Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis","volume":"234","author":"Li","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12967-014-0231-0","article-title":"The impact of microRNA-mediated PI3K\/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer","volume":"12","author":"Dong","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0231-4","article-title":"Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1\/CXCR4 axis","volume":"9","author":"Teng","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Barrett, R.L., and Pur\u00e9, E. (2020). Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. eLife, 9.","DOI":"10.7554\/eLife.57243"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3389\/fonc.2019.01073","article-title":"The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies","volume":"9","author":"Marinelli","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Inoue, C., Miki, Y., Saito, R., Hata, S., Abe, J., Sato, I., Okada, Y., and Sasano, H. (2019). PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells. Cancers, 11.","DOI":"10.3390\/cancers11091257"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3892\/ijo.2016.3631","article-title":"Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR\/CD155), a ligand of activating NK receptor","volume":"49","author":"Inoue","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/his.12584","article-title":"Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma","volume":"66","author":"Qu","year":"2014","journal-title":"Histopathology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1242\/jcs.1.3.297","article-title":"Growth Inhibition of Polyoma-Transformed Cells by Contact with Static Normal Fibroblasts","volume":"1","author":"Stoker","year":"1966","journal-title":"J. Cell Sci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Wang, Z., Yang, Q., Tan, Y., Tang, Y., Yet, J., Yualn, B., and Yu, W. (2021). Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.613534"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2018-316451","article-title":"Stromal biology and therapy in pancreatic cancer: Ready for clinical translation?","volume":"68","author":"Neesse","year":"2019","journal-title":"Gut"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm.2328","article-title":"Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression","volume":"17","author":"Bissell","year":"2011","journal-title":"Nat. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/cas.14346","article-title":"Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives","volume":"111","author":"Miyai","year":"2020","journal-title":"Cancer Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9121\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:50:33Z","timestamp":1760165433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":88,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22179121"],"URL":"https:\/\/doi.org\/10.3390\/ijms22179121","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}